TRV GP III’s Voyager Therapeutics VYGR Stock Holding History

TRV GP III’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,185,291	Closed	-$24.6M	–	3
2023 Q1	$24.6M	Sell	3,185,291 -2,243,642	-41%	-$17.8M	29.6%	2
2022 Q4	$33.1M	Hold	5,428,933	–	–	25.95%	3
2022 Q3	$32.1M	Sell	5,428,933 -962,243	-15%	-$6.16M	14.03%	3
2022 Q2	$37.8M	Hold	6,391,176	–	–	15.45%	3
2022 Q1	$48.7M	Hold	6,391,176	–	–	13.21%	3
2021 Q4	$17.3M	Hold	6,391,176	–	–	4.33%	5
2021 Q3	$16.8M	Hold	6,391,176	–	–	3.19%	7
2021 Q2	$26.4M	Hold	6,391,176	–	–	4.61%	6
2021 Q1	$30.1M	Hold	6,391,176	–	–	3.81%	7
2020 Q4	$45.7M	Hold	6,391,176	–	–	3.92%	6
2020 Q3	$68.2M	Hold	6,391,176	–	–	5.73%	5
2020 Q2	$80.7M	Hold	6,391,176	–	–	11.77%	4
2020 Q1	$58.5M	Hold	6,391,176	–	–	15.91%	3
2019 Q4	$89.2M	Hold	6,391,176	–	–	39.37%	2
2019 Q3	$110M	Hold	6,391,176	–	–	62.32%	1
2019 Q2	$174M	Hold	6,391,176	–	–	73.96%	1
2019 Q1	$122M	Hold	6,391,176	–	–	59.92%	1
2018 Q4	$60.1M	Hold	6,391,176	–	–	50.34%	1
2018 Q3	$121M	Sell	6,391,176 -1,500,000	-19%	-$28.8M	54%	1
2018 Q2	$154M	Sell	7,891,176 -1,500,000	-16%	-$29.6M	51.35%	1
2018 Q1	$176M	Hold	9,391,176	–	–	63.52%	1
2017 Q4	$156M	Buy	+9,391,176	New	+$161M	54.58%	1

Other funds holding VYGR

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

TRV GP III's VYGR Position: Q2 2023 in Review

TRV GP III sold out of Voyager Therapeutics (VYGR) in Q2 2023, closing a stake of 3,185,291 shares — an estimated $24.6M sold.

TRV GP III first reported a position in VYGR in Q4 2017 and held it in 22 quarters. The position peaked at $176M in Q1 2018. 106 funds tracked by Wall St. Rank hold VYGR as of Q2 2023.

TRV GP III reported no remaining Voyager Therapeutics position as of Q2 2023 after selling out during the quarter.
TRV GP III sold 3,185,291 Voyager Therapeutics shares in Q2 2023, an estimated $24.6M.
TRV GP III first reported a position in Voyager Therapeutics in Q4 2017 and held it in 22 quarters.
TRV GP III's Voyager Therapeutics position peaked at $176M in Q1 2018.
106 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2023.

Based on TRV GP III's 13F filing for Q2 2023, filed 10 Aug 2023.